- Previous Close
7.14 - Open
7.08 - Bid 7.09 x --
- Ask 7.12 x --
- Day's Range
6.94 - 7.27 - 52 Week Range
5.62 - 10.95 - Volume
26,574,090 - Avg. Volume
22,311,691 - Market Cap (intraday)
7.966B - Beta (5Y Monthly) 0.76
- PE Ratio (TTM)
47.40 - EPS (TTM)
0.15 - Earnings Date --
- Forward Dividend & Yield 0.08 (1.13%)
- Ex-Dividend Date Jul 15, 2024
- 1y Target Est
--
Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sale of veterinary products in China. Its product portfolio includes Jinyu Baoling, Yangzhou Youbang, and Liaoning Yikang animal vaccines for the prevention of foot, porcine, mycoplasma pneumoniae, porcine reproductive and respiratory syndrome, porcine pseudorabies, pathogenic avian influenza, brucellosis bacterial disease, bovine viral diarrhea and mucosal, infectious rhinotracheitis, and other domestic animal diseases. The company was founded in 1992 and is headquartered in Hohhot, China.
www.jinyu.com.cnRecent News: 600201.SS
View MorePerformance Overview: 600201.SS
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600201.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600201.SS
View MoreValuation Measures
Market Cap
7.97B
Enterprise Value
6.66B
Trailing P/E
47.40
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.83
Price/Book (mrq)
1.47
Enterprise Value/Revenue
4.93
Enterprise Value/EBITDA
36.22
Financial Highlights
Profitability and Income Statement
Profit Margin
12.21%
Return on Assets (ttm)
0.98%
Return on Equity (ttm)
2.90%
Revenue (ttm)
1.35B
Net Income Avi to Common (ttm)
164.86M
Diluted EPS (ttm)
0.15
Balance Sheet and Cash Flow
Total Cash (mrq)
1.31B
Total Debt/Equity (mrq)
0.06%
Levered Free Cash Flow (ttm)
211.88M